Key result
Coronary revascularization was not significantly associated with an increased risk of incident dementia compared with no revascularization among older adults with acute coronary syndrome (sub-HR 1.05, 95% CI 0.95-1.17, p=0.36).
Why the study?
Cognitive decline has been reported after coronary revascularization, but whether it reflects procedure-specific effects or underlying vascular disease burden remains uncertain.
Does coronary revascularization increase the risk of incident dementia compared to medical management in older adults hospitalized with acute coronary syndrome?
Cohort (n=25,176)
Yes
Does coronary revascularization increase the risk of incident dementia compared to medical management in older adults hospitalized with acute coronary syndrome?
Hazard Ratio: 1.05 (95% CI 0.95–1.17)
Absolute Event Rate: 9.3% vs 8.9%
p-value: p=0.36
Coronary revascularization in older adults with ACS does not increase the long-term risk of dementia compared to medical management, suggesting cognitive decline is driven by underlying vascular disease rather than procedure-specific neurotoxicity.
May reassure on dementia risk with revascularization in older ACS patients; challenges prior reports of post-procedure harm and leaves open vascular disease mechanisms.
BACKGROUND: Cognitive decline has been reported after coronary artery revascularization, but whether it reflects procedure-specific effects or the burden of underlying vascular disease remains uncertain. OBJECTIVES: To determine whether incident dementia risk differs according to coronary revascularization strategy among older adults with acute coronary syndrome (ACS). METHODS: We conducted a longitudinal cohort study among adults aged ≥65 years hospitalized for ACS between 2010 and 2020 (n = 25,176). Patients underwent percutaneous coronary intervention (n = 8,043), coronary artery bypass grafting (n = 797), or received no revascularization (n = 16,336). A second comparator cohort included patients with stable coronary artery disease (CAD) without revascularization (n = 154,299). The primary outcome was incident dementia identified using validated International Classification of Diseases codes after a 1-year washout. Propensity-matched analyses used Cox models accounting for the competing risk of death. RESULTS: Revascularized patients were younger (74.8 ± 6.9 vs 77.1 ± 8.2 years), more often male (66.2% vs 54.0%), and had lower Elixhauser multimorbidity scores (4.6 ± 2.8 vs 5.4 ± 3.0, all P < 0.001). Over a median 4.8 years of follow-up, 9.0% of ACS patients developed dementia. Revascularization was not associated with increased dementia risk compared with ACS without revascularization (sub-hazard ratio: 1.05; 95% CI: 0.95-1.17) or stable CAD. Dementia risk was also similar between percutaneous coronary intervention and coronary artery bypass grafting. CONCLUSIONS: We found that among older adults with ACS, coronary revascularization was not statistically significantly associated with increased dementia risk compared with no revascularization or stable CAD. These findings reflect the hypothesis that the majority of dementia risk is potentially driven more by cumulative vascular and systemic factors than by procedure-specific neurotoxicity.
No takes yet. Share an insight, caveat, or question.
Krishnaswami et al. (2026) conducted a cohort in Acute Coronary Syndrome (n=25,176). Coronary revascularization (PCI or CABG) vs. No revascularization (medical management) was evaluated on Incident dementia after a 1-year washout (sub-HR 1.05, 95% CI 0.95-1.17, p=0.36). Coronary revascularization was not significantly associated with an increased risk of incident dementia compared with no revascularization among older adults with acute coronary syndrome (sub-HR 1.05, 95% CI 0.95-1.17, p=0.36).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: